Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • OptiMaser signs an MOU...

    OptiMaser signs an MOU with IITR to synergize Microwave technology for Infection Control

    Written by Ruby Khatun Khatun Published On 17 Jun 2017 6:01 AM  |  Updated On 17 Jun 2017 6:01 AM
    OptiMaser signs an MOU with IITR to synergize Microwave technology for Infection Control

    Lucknow: In another big step towards realizing a massive movement of the hon’ble Prime Minister Shri Narendra Modi that seeks to create a Clean India “Swachh Bharat” Abhiyan, OptiMaser, a path breaking product that treats biomedical waste across the nation, sets to revolutionize this sector by signing an MoU Agreement with India’s only Indian Institute of Toxicology Research (CSIR-IITR).


    OptiMaser has created history by aligning with IITR for its clinical and translational research in the field of antibacterial, micro/nano mechanical materials, advanced applications.


    The MoU was successfully signed in Lucknow on 2nd June 2017 between Dr. Alok Dhawan (Director IITR) and Mr. Monish Bhandari (Executive Director SSMED).


    A top notch team headed by India’s leading scientists/microbiologists/ industrialists including Dr. Rishi Shanker, Mr. Monish Bhandari & Dr. Mohan Kamthan will now work closely with OptiMaserTM and its clinical applications.


    According to MoU, the Microwave Assisted Clinical group headed by Dr. Rishi Shanker, will research within strict stipulated time on microwave’s clinical application. OptiMaser in turn will incorporate these clinical references into instant commercialization at its state of art two manufacturing facilities located at Gurugram (Haryana) & Lucknow (UP).


    Today, with milestones set, the group will develop dedicated cycles for clinical translational research using OptiMaserTM microwave technology, which has never been tried or conceptualised anywhere in the world before.


    The tech group shall collectively work on the following:




    1. Class A drugs desynthesis/ inactivation

    2. Rice Husk Disinfection

    3. Cages Disinfection

    4. Dialyzer Disinfection for reuse

    5. Blood Bag Disinfection

    6. O.T. Linen Sterilization

    7. Plastic tubing sterilization for reuse.

    8. Metal items sterilization for reuse


    On this momentous occasion, Mr. Monish Bhandari, Executive Director, OptiMaser, said “We are excited about the tremendous growth that our collaboration with IITR will bring with progressive innovations in Microwave Technology for Infection Control. The MoU is a big step forward because it combines the strengths of two powerhouses of Indian academia & industry. OptiMaser will closely collaborate with IITR in realizing India’s infection & epidemic control/ management optimization, through extensive research on infection control.


    We are already pioneers in bio-waste management, and are set to reach greater heights by closely working with one of the world’s prestigious institutes for toxicology research. This collaboration is set to bring a paradigm shift in infection control with zero impact on environment.”


    Amid discussion, Prof. Dr. Alok Dhawan, Director, IITR, said “the product fully developed would entirely disrupt the existing technology of Autoclave. OptiMaserTMconsumes 1/10th of the power with Zero Emission... mobile.. & completely destroys all harmful bacteria instantly”


    Test runs for the aforesaid cycles would be initiated in July 2017 with ethical validation proposed from leading institutes in India, Singapore & Europe.

    Dr Alok DhawanDr Mohan KamthanDr Rishi ShankerIITRIndian Institute of Toxicology ResearchInfection ControlMicrowave technologyMonish BhandariMoUNarendra ModiOptiMaserPrime MinisterSwachh Bharat Abhiyan
    Source : PRESS RELEASE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok